Although both high expression of E2F4 in advanced GC and its correlation with poor prognosis are seemingly contradictory to the repressive role of E2F4 in cell cycle control, there are existing studies supporting an oncogenic role of E2F4. Here, E2F4 is linked to gastric cancer.